HF
QNRX

HRT Financial’s Quoin Pharmaceuticals QNRX Stock Holding History

HRT Financial’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-792
Closed -$18K – 3236
2024
Q4 		$18K Buy
+792
New +$18.2K ﹤0.01% 2224
2024
Q2 		– Sell
-866
Closed -$28K – 2931
2024
Q1 		$28K Buy
+866
New +$85.4K ﹤0.01% 1984
2022
Q3 		– Sell
-2
Closed -$4K – 3357
2022
Q2 		$4K Sell
2
-1
-33% -$3.98K ﹤0.01% 2758
2022
Q1 		$20K Buy
+3
New +$22.4K ﹤0.01% 2833
2021
Q3 		– Sell
-1
Closed -$48K – 3671
2021
Q2 		$48K Hold
1
– – ﹤0.01% 2680
2021
Q1 		$65K Buy
+1
New +$69.8K ﹤0.01% 2512
2020
Q4 		– Sell
-1
Closed -$56K – 2340
2020
Q3 		$56K Buy
+1
New +$57.8K ﹤0.01% 1651

Other funds holding QNRX

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HRT Financial's QNRX Position: Q1 2025 in Review

HRT Financial sold out of Quoin Pharmaceuticals (QNRX) in Q1 2025, closing a stake of 792 shares — an estimated $18K sold.

HRT Financial first reported a position in QNRX in Q3 2020 and held it in 7 quarters. The position peaked at $65K in Q1 2021. 9 funds tracked by Wall St. Rank hold QNRX as of Q1 2025.

  • HRT Financial reported no remaining Quoin Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 792 Quoin Pharmaceuticals shares in Q1 2025, an estimated $18K.
  • HRT Financial first reported a position in Quoin Pharmaceuticals in Q3 2020 and held it in 7 quarters.
  • HRT Financial's Quoin Pharmaceuticals position peaked at $65K in Q1 2021.
  • 9 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.